Ferritin clinical trials
13 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones look like a fit.
- Oral Iron in Children With Chronic Kidney Disease
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Restoring Iron Deficiency in POTS
- Study of DISC-0974-201 in Participants With IBD and Anemia
- Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
- IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
- Kids With Iron Deficiency and Scoliosis
- Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
- Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
- A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep
- Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “Ferritin” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.